SMC Entertainment (SMCE) Stock Price, News & Analysis

Company Overview

SMC Entertainment, Inc. focuses on the acquisition and support of financial technology companies in the United States. The company develops and provides technology that combines artificial intelligence (AI) /machine learning (ML) driven Quantitative investing (IQ Engine) with AI-enabled wealth management tools; and offers IQ Engine, an AI driven contextual analyzer that creates a repository of various equity research. It markets a software-as-a-service (SaaS) proprietary platform for certified public accountants, financial institutions, and registered investment advisors. The company was formerly known as SMC Recordings, Inc. and changed its name to SMC Entertainment, Inc. in May 2011. SMC Entertainment, Inc. was incorporated in 1998 and is based in Boca Raton, Florida.

Key Stats

• Today's Range: $0.0011 to $0.0013
• 50-Day Range: N/A
• 52-Week Range: $0.0005 to $0.0079
• Volume: 961,422 shs
• Average Volume: 5.45 million shs
• Market Capitalization: $1.69 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SMCE Stock Analysis - Frequently Asked Questions

How have SMCE shares performed this year?

SMC Entertainment's stock was trading at $0.0006 at the start of the year. Since then, SMCE shares have increased by 108.3% and is now trading at $0.0013.
View the best growth stocks for 2024 here.

How do I buy shares of SMC Entertainment?

Shares of SMCE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of SMC Entertainment own?

Based on aggregate information from My MarketBeat watchlists, some other companies that SMC Entertainment investors own include General Electric (GE), Grayscale Bitcoin Trust (GBTC), Ford Motor (F), Ellington Credit (EARN), Daré Bioscience (DARE), Cronos Group (CRON) and Celldex Therapeutics (CLDX).

Company Calendar

• Last Earnings: 8/22/2024
• Today: 11/20/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Consumer Discretionary
• Industry: Data processing & preparation
• Sub-Industry: Business Services
• Current Symbol: OTCMKTS:SMCE
• CUSIP: N/A
• CIK: 1497230
• Web: www.smcrecordings.com
• Phone: (360) 820-5973
• Fax: N/A
• Employees: 5
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-1,560,000.00
• Net Margins: N/A
• Pretax Margin: -1,523,418.62%
• Return on Equity: -8.75%
• Return on Assets: -235.79%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,352,951,000
• Free Float: 795,535,000
• Market Cap: $1.69 million
• Optionable: Not Optionable
• Beta: 0.64